Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Instruments Announces Establishment of Korean Office

Published: Tuesday, March 01, 2011
Last Updated: Tuesday, March 01, 2011
Bookmark and Share
Managed by Mr. Yunki Kyung, the new direct sales and service organization will focus on growing BioTek's brand and expanding direct service and application support for our growing customer base in South Korea.

BioTek Korea will be fully functional by July 1, 2011. BioTek's long-time partner and distributor, DI Biotech, will work closely with BioTek Korea to ensure a seamless transition for the company's existing and expanding customer base.

"The establishment of BioTek Korea will allow BioTek to increase our investment of resources in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing incremental local service and application support, our customers in South Korea will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Korean customers."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioTek Continues International Growth with Launch of BioTek France
BioTek France team includes Dr. Dirk Frese, Philippe Vivier, Damien Brechet and Lionel Capelle.
Wednesday, January 25, 2012
BioTek Offers Service Through Serlabo in France
Serlabo will provide IQ/OQ/PQ, primary training, service, preventative maintenance and service contracts for users of BioTek's microplate instrumentation.
Friday, January 06, 2012
BioTek Recognized with 5x5x5 Award Again
BioTek receives the Award at the 9th annual awards ceremony on Thursday, September 15, 2011.
Saturday, September 17, 2011
BioTek Welcomes New Product Specialist to Cover Expanding Brazilian Market
BioTek Instruments, Inc. welcomes Marcus Stolarski to the company as Product Specialist. Marcus is responsible for supporting BioTek's distribution network and customers in Brazil.
Thursday, March 10, 2011
BioTek Announces New Applications and Business Development Manager in Canada
Dr Charles Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.
Monday, February 28, 2011
BioTek’s Synergy H1 Receives HTRF Certification
The latest addition to the patent-pending Hybrid Microplate Reader family has received HTRF® certification from Cisbio Bioassays.
Thursday, September 23, 2010
BioTek Instruments and Global Cell Solutions Collaborate at LabAutomation2010
Collaborators announce a new poster detailing the use of BioTek’s microplate instrumentation for various cell-based assays.
Friday, January 29, 2010
BioTek Instruments Launches International Web Sites
Company announces the availability of multi-lingual web sites for international customers.
Thursday, July 30, 2009
Introducing Scientifically Speaking - A Microplate Instrumentation Blog by BioTek Scientists
BioTek scientists are reaching out to the online community through their new blog providing general expertise for microplate instrumentation.
Thursday, July 16, 2009
BioTek Instruments Introduces new Web Site
The new web site, that soon will be available in multiple languages, has improved technical and application resources for life science and drug discovery markets.
Wednesday, February 25, 2009
DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
The DLR Assay System provides quantitation of firefly and Renilla luciferase reporters in transfected cells.
Wednesday, November 08, 2006
BioTek Delivers Support through Interactive Program
Qualified customers are introduced to the Winooski, VT facility with a brief plant tour.
Tuesday, September 12, 2006
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!